TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Pharmor AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
332
|
268
|
273 |
| Financial expenses |
29
|
39
|
57 |
| Earnings before taxes |
145
|
83
|
107 |
| EBITDA |
148
|
117
|
129 |
| Total assets |
521
|
410
|
371 |
| Current assets |
132
|
171
|
155 |
| Current liabilities |
91
|
82
|
64 |
| Equity capital |
391
|
296
|
277 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
75.0%
|
72.2%
|
74.7% |
| Turnover per employee |
332
|
268
|
273 |
| Profit as a percentage of turnover |
43.7%
|
31.0%
|
39.2% |
| Return on assets (ROA) |
33.4%
|
29.8%
|
44.2% |
| Current ratio |
145.1%
|
208.5%
|
242.2% |
| Return on equity (ROE) |
37.1%
|
28.0%
|
38.6% |
| Change turnover |
63
|
17
|
46 |
| Change turnover % |
24%
|
7%
|
20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.